Fermenta Biotech Ltd has been Great Place to Work-Certified19 Jul 2019
Fermenta Biotech Ltd has cleared the required qualification criteria to become Great Place to Work-Certified.
Great Place to Work® is the global authority in creating, assessing and identifying the Best Workplaces world over.
Every year, more than 10,000 organisations from over 60 countries partner with Great Place to Work® Institute for assessment, bench-marking and planning actions to strengthen their workplace culture. In India, more than 900 organizations applied to Great Place to Work® Institute to undertake the assessment this year, making it the largest Study in the space of Workplace Recognition. The Institute uses 2 lenses to evaluate and identify the best cultures.
The first lens measures the quality of employee experience through their globally validated survey instrument known as Trust Index©. The second lens is called Culture Audit©, a proprietary tool of the Institute that evaluates the people practices of an organisation, covering the entire employee life-cycle.
Fermenta Biotech Ltd. cleared the required qualification criteria on the 2 lenses above and got Great Place to Work – CertifiedTM, a recognition considered the ‘Gold Standard’ in ‘Employer of Choice’ recognitions and awarded to less than 50% of the participants every year. Fermenta has excelled on the 5 dimensions of creating and sustaining a High-Trust, High-Performance CultureTM – Fairness, Credibility,Respect, Pride and Camaraderie.
Samsung Biologics expands business continuity excellence with additional ISO 22301 certification
19 May 2020
The certification is expected to instill greater 'supply' trust with clients, particularly during the current pandemic.Read more
KND Labs earns Active Pharmaceutical Ingredients certification for CBD ingredients
12 May 2020
Company's manufacturing methods and processes reviewed by an independent third-party auditor to ensure the products have the highest-quality ingredients possible.Read more
EMA to only issue electronic medicines certificates during COVID-19 pandemic
30 Mar 2020
The European Medicines Agency (EMA) said Monday it will only issue electronically signed and authenticated certificates for human and veterinary medicines in place of printed ones so it can continue to provide the documents during the COVID-19 pandemic...Read more
Lupin could face FDA regulatory action over Tarapur API facility
13 Jan 2020
India’s Lupin Pharmaceuticals warned Monday it could face regulatory sanctions from the US Food and Drug Administration over its Tarapur active pharmaceutical ingredient (API) manufacturing facility.Read more
Accreditation Certification of Foreign Drug Manufacturer from Japan PMDA
7 Oct 2019
In 2018, an Accreditation Certificate of Foreign Drug Manufacturer was
certified to Heron’s manufacturing base by Japan Pharmaceutical and Medical
Devices Agency (PMDA, No. AG10500666).
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation